(많-이 철지난) 케어젠 디글루스테롤 FDA NDI 논쟁 종결
버프 텔레그램 https://t.me/bufkr

아래 FDA "Health Claims"에 대한 원문 중 발췌
https://www.fda.gov/food/food-labeling-nutrition/questions-and-answers-health-claims-food-labeling

3. Does the FDA review qualified health claims?
Yes. All health claims, whether authorized or qualified, require pre-market review by the FDA. Under federal law, the FDA approves by regulation authorized health claims for use in food labeling only if the substance/disease relationship described by the health claim meets the "significant scientific agreement" standard. For qualified health claims, the FDA issues letters of enforcement discretion when there is credible evidence to support the claim.

Q. FDA가 모든 "효능에 대한 주장"을 검토합니까?
A. 넵, 그게 어떤 타입이든, 모든 "효능 주장"은 해당 주장을 뒷받침하기 위해 충분한 과학적 근거가 있는지 실제 제품 출시 전에 FDA로부터 리뷰를 받아야만 합니다.

(많-이 철지난) 케어젠 디글루스테롤 FDA NDI 논쟁 종결
버프 텔레그램 https://t.me/bufkr

아래 FDA "Health Claims"에 대한 원문 중 발췌
https://www.fda.gov/food/food-labeling-nutrition/questions-and-answers-health-claims-food-labeling

3. Does the FDA review qualified health claims?
Yes. All health claims, whether authorized or qualified, require pre-market review by the FDA. Under federal law, the FDA approves by regulation authorized health claims for use in food labeling only if the substance/disease relationship described by the health claim meets the "significant scientific agreement" standard. For qualified health claims, the FDA issues letters of enforcement discretion when there is credible evidence to support the claim.

Q. FDA가 모든 "효능에 대한 주장"을 검토합니까?
A. 넵, 그게 어떤 타입이든, 모든 "효능 주장"은 해당 주장을 뒷받침하기 위해 충분한 과학적 근거가 있는지 실제 제품 출시 전에 FDA로부터 리뷰를 받아야만 합니다.